A Call to Action: Speak Up to End the Shortage of Stimulant Medication

A Call to Action: Speak Up to End the Shortage of Stimulant Medication

Millions of Americans with Attention Deficit Hyperactivity Disorder (ADHD) rely on stimulant medications to manage their symptoms. However, the recent nationwide shortage has disrupted access to these essential drugs. The result has been devastating for so many people, significantly impacting daily life, causing difficulties with focus, hyperactivity, and emotional regulation.

You can help make a difference, by:

1. Engaging with Regulatory Agencies: Submitting comments to the Federal Trade Commission (FTC) and the Department of Health and Human Services (HHS) raises awareness and encourages them to advocate for increased production and distribution.

2. Contacting Your Representatives: Reach out to your U.S. Congressional Representatives to push for policies that streamline production and distribution while ensuring safeguards.

3. Communicating with the DEA: Sending a letter to the DEA expresses the urgency of the situation and highlights the need for reevaluating production quotas to ensure sufficient supply.

4. Connecting with the FDA: Contacting the FDA can encourage them to expedite the approval process for alternative or generic medications, increasing access for patients.

Use the link below to find contact information for your Representatives, form letters, and more resources to help you take action.

New APSARD Strategic Plan!

New APSARD Strategic Plan!

VISION, MISSION, VALUES

VISION

Improving the lives of people with ADHD

MISSION

Promote interdisciplinary communication among researchers, clinicians, and educators to enhance the care for individuals living with ADHD throughout their lifespan. This is achieved by advancing and disseminating scientific knowledge in collaboration with researchers and practitioners in order to implement evidenced-based practices and policies.

VALUES

Commitment to:

• Excellence in science and practice

• Integrity in education

• Diversity, equity and inclusion

• Well-being of the community

GOALS

Advance and disseminate the research base in ADHD and promote the translation of the findings for clinical practice

Objectives

Improve access to the latest science and evidence-based practices for treatment of ADHD

Increase training opportunities at all levels

Establish a research plan

Promote generative discussions amongst researchers and practitioners

Understand and address the needs of the communities related to ADHD

Objectives

Gain insights through active engagement

Collaborate with partner organizations

Reflect the biopsychosocial determinants of ADHD course and outcome

Address the intersectionality of ADHD and adverse health outcomes

Expand opportunities for engagement and professional enhancement with APSARD

Objectives

Maintain and expand opportunities for clinicians and researchers to interact

Become a primary educational resource for ADHD

Develop value proposition for membership

Build alliances with national and international professional organizations

Strengthen the standing of APSARD as a leading and respected voice in ADHD

Objectives

Lead by example in support of the ADHD communities

Communicate the value of APSARD

Diversify funding sources for research, education and advocacy

Actively participate in advocacy and policy fostering the well-being of the ADHD communities

An Interview with Gregory W. Mattingly, MD, President Elect in the Psychiatric Times

An Interview with Gregory W. Mattingly, MD, President Elect in the Psychiatric Times

We, at APSARD, are eagerly anticipating the kick-off of our 2024 conference in Orlando, Florida, on January 18th! This year’s conference promises to be even more exciting and informative than ever before, with a focus on ADHD across special populations, groundbreaking research, and practical tools for clinical practice.

To learn more about what you can expect from the APSARD 2024 conference, be sure to watch this interview with APSARD President-Elect Dr. Gregory W. Mattingly. In this interview, Dr. Mattingly discusses the conference’s highlights, why he’s so excited about this year’s event, and how APSARD is working to improve outcomes for individuals with ADHD.

Watch the interview by clicking the preview.